SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer and Treasurer
NEW YORK, April 20, 2018 -- (Healthcare Sales & Marketing Network) -- SELLAS Life Sciences Group Inc., (Nasdaq:SLS) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer indications, today ... Biopharmaceuticals, Oncology, Personnel SELLAS Life Sciences, galinpepimut-S, Wilms Tumor 1
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Genetics | Immunotherapy | Marketing | Pharmaceuticals | Wilm's Tumor